Cargando…

Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simple steatosis to inflammatory steatohepatitis (NASH) with different degrees of fibrosis that can ultimately progress to cirrhosis. Accumulating evidence suggests the involvement of the endocannabinoid-system in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Francesca, Bellini, Giulia, Alisi, Anna, Alterio, Arianna, Maione, Sabatino, Perrone, Laura, Locatelli, Franco, del Giudice, Emanuele Miraglia, Nobili, Valerio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426511/ https://www.ncbi.nlm.nih.gov/pubmed/22927922 http://dx.doi.org/10.1371/journal.pone.0042259

Ejemplares similares

The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche
por: Bellini, Giulia, et al.
Publicado: (2015)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties
por: Rossi, Francesca, et al.
Publicado: (2013)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
por: Alisi, Anna, et al.
Publicado: (2011)

The role of cannabinoid receptor 2 in oligo/poly-articular juvenile idiopathic arthritis
por: Gicchino, Maria F, et al.
Publicado: (2014)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
por: Paschetta, Elena, et al.
Publicado: (2015)

Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C
por: Coppola, Nicola, et al.
Publicado: (2014)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children
por: Di Sessa, Anna, et al.
Publicado: (2017)

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Nobili, Valerio, et al.
Publicado: (2014)

Role of Cannabinoids in Obesity
por: Rossi, Francesca, et al.
Publicado: (2018)

Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
por: Di Sessa, Anna, et al.
Publicado: (2019)

Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
por: Nobili, Valerio, et al.
Publicado: (2016)

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
por: Corte, Claudia Della, et al.
Publicado: (2011)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
por: Pastore, Anna, et al.
Publicado: (2014)

Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics
por: Riccio, Simona, et al.
Publicado: (2022)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

The Role of Cannabinoid Receptors in the Descending Modulation of Pain
por: Palazzo, Enza, et al.
Publicado: (2010)

ADAR Enzyme and miRNA Story: A Nucleotide that Can Make the Difference
por: Tomaselli, Sara, et al.
Publicado: (2013)

Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
por: Alisi, Anna, et al.
Publicado: (2013)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
por: Di Sessa, Anna, et al.
Publicado: (2020)

Metabolic syndrome
por: Corte, Claudia Della, et al.
Publicado: (2015)

Is Non-Alcoholic Fatty Liver Disease Less Frequent among Women with Prader-Willi Syndrome?
por: Bedogni, Giorgio, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood
por: Di Sessa, Anna, et al.
Publicado: (2021)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
por: Giorgio, Valentina, et al.
Publicado: (2013)

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
por: Ceccarelli, Sara, et al.
Publicado: (2015)

Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity
por: Di Bonito, Procolo, et al.
Publicado: (2022)

Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD
por: Alisi, Anna, et al.
Publicado: (2018)

Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway
por: Carpino, Guido, et al.
Publicado: (2016)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents
por: Ezaizi, Yamen, et al.
Publicado: (2019)

Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions
por: Lanzaro, Francesca, et al.
Publicado: (2022)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

The Association of PNPLA3 Variants with Liver Enzymes in Childhood Obesity Is Driven by the Interaction with Abdominal Fat
por: Miraglia del Giudice, Emanuele, et al.
Publicado: (2011)

The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
por: Cetin, Elif Guven, et al.
Publicado: (2020)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_so8gibh9b3ft3f3g7jttmk6sph